Most studies indicate that IDO1 is correlated with poor prognosis in various cancer types, such as ovarian cancer, esophageal cancer, and penile squamous cell carcinoma (Yu et al., 2018; Kiyozumi et al., 2019; Zhou et al., 2020). This evidence concerns the gene IDO1 and ovarian cancer.